ASCO Backs Routine ESR1 Testing for Certain Breast Cancers Activity of elacestrant in EMERALD trial "provides strong signal" for guideline update May 18, 2023
Survival Boost With Oncolytic Virus Combo in Glioblastoma Subset However, small trial failed to meet overall response endpoint in patients with recurrent disease May 16, 2023
Dermatologists Hone Diagnostic Accuracy for Suspect Lesions With AI 'Collaboration' Sensitivity, specificity, mean accuracy, and AUC improved significantly with neural network input May 16, 2023
Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AML But trial detects "meaningful benefit" when it comes to relapse, editorialists say May 15, 2023
Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer News, features, and commentary about cancer-related issues May 12, 2023
CDC: Drug-Resistant Ringworm in U.S.; Mail-In HPV Tests Work; Pope Urges Procreation Health news and commentary from around the Web gathered by staff May 12, 2023
Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomas Results will likely "encourage a practice change," editorialists say May 10, 2023
FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemia Median OS improved from 15 months to nearly 32 months with quizartinib May 09, 2023
AI in Colonoscopy: Disconnect Grows Between Academic, Community Studies Clearly helpful in manufacturers' trials, but not so much in routine practice May 09, 2023
Proposed Breast Cancer Screening Guidelines Are Good, but Not Enough Specifics for older women, Black women, and those with dense breasts are needed May 09, 2023
Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
Study: VA Surgeons Who Do Colonoscopies May Need More Training Outdone by gastroenterologists in finding adenomatous polyps May 08, 2023
Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer Small but clear boost to overall survival May 07, 2023
Medicaid Expansion Seen Lifting Colon Cancer Screening for Low-Income People But not a cure-all in states boosting eligibility May 06, 2023
Food 'Swamps' Tied to Elevated Mortality From Obesity-Related Cancers Study suggests diet is not necessarily a modifiable risk factor for all, editorialists say May 05, 2023
Mysterious White Blood Cell Disorder Not Just 'AIDS Without HIV' Idiopathic CD4 lymphocytopenia not so heterogenous after all May 03, 2023
Implanted Ultrasound Device Opening Blood-Brain Barrier Promising in Brain Tumors Device allows delivery of more potent chemotherapies to patients with glioblastomas May 03, 2023
B-Cell Stimulating Factors Tied to Lymphoma in Sjogren's Findings may bolster interest in BTK inhibitors for autoimmune diseases May 02, 2023
Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer Complete responses in 73% of patients with BCG-unresponsive non-muscle-invasive disease May 02, 2023
Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancer Two studies suggest no harm from deferred cytoreduction, potential benefits of immunotherapy May 02, 2023
Thriving After Cancer Tara Sanft, MD, on how clinicians can support patients through difficult times May 02, 2023 podcast
'Fantastic,' 'Terrific' Results With Oncolytic Virus Combo for Bladder Cancer Complete response rate of 85% in BCG-unresponsive non-muscle-invasive disease May 01, 2023
Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer Combo has potential to be new standard of care in patients with high-risk BCR, expert says Apr 30, 2023
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Dies Health news and commentary from around the Web gathered by staff Apr 28, 2023
Sodium Thiosulphate Not Much Help for Calciphylaxis in CKD Though used off-label for years, treatment isn't very beneficial Apr 26, 2023
Blinatumomab Plus Chemo Effective in Aggressive Infant ALL Low incidence of relapse after treatment "remarkable," researchers say Apr 26, 2023
HIPEC With Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancer No increase in adverse events or toxicity versus surgery alone Apr 26, 2023
Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive News, features, and commentary about cancer-related issues Apr 21, 2023
Manufacturer's Troponin Reference Values Don't Apply to Kids Different thresholds for myocardial injury suggested for pediatric patients Apr 21, 2023
Awareness of HPV's Link to Cancer Lags as Cases Continue to Increase Clear decline for cervical cancer, awareness of other cancers remains stagnant Apr 21, 2023
Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCL Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
Genomics Add Insight Into Worse Colorectal Cancer Outcomes in Black Patients Fewer actionable mutations, less likely to meet genomic criteria for immunotherapy Apr 19, 2023
CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancer ORR of 30% in patients with CD70-positive disease using off-the-shelf, allogeneic product Apr 19, 2023
Many With Cancer Predisposition Diseases Unaware of Genetic Status Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Women It's less clear-cut for postmenopausal women, study authors say Apr 18, 2023
Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
Novel Antibody Induces Durable Responses in Heavily Pretreated Myeloma Overall response rate of 90% in patients who received highest doses of REGN5459 Apr 18, 2023
Novel Bispecific Antibody Active in Recurrent/Metastatic Head and Neck Cancer Responses in 37% of patients previously treated with anti-PD-1/L1 agents, platinum chemotherapy Apr 18, 2023
Responses to PD-1 Blockade Approach 90% in Rare Melanoma "One of the highest tumor response rates we've seen in any cancer," study discussant says Apr 17, 2023
